Breast Cancer Research and Treatment

Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers
pp. 99-105(7)
Authors: Levêque J.; Levêque J.; Foucher F.; Bansard J-Y.; Havouis R.; Grall J-Y.; Moulinoux J-P.

T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice
pp. 107-115(9)
Authors: Chen D.; Koido S.; Li Y.; Gendler S.; Gong J.

Cellular responses of mammary carcinomas to aromatase inhibitors: Effects of vorozole
pp. 117-128(12)
Authors: Christov K.; Shilkaitis A.; Green A.; Mehta R.G.; Grubbs C.; Kelloff G.; Lubet R.

Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells
pp. 129-134(6)
Authors: Divino C.M.; Chen S-H.; Yang W.; Thung S.; Brower S.T.; Woo S.

Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer
pp. 135-142(8)
Authors: Siah S.P.; Siah S.P.; Quinn D.M.; Bennett G.D.; Casey G.; Flower R.L.; Suthers G.; Rudzki Z.

RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters
pp. 143-151(9)
Authors: Kahn H.J.; Yang L-Y.; Blondal J.; Lickley L.; Holloway C.; Hanna W.; Narod S.; McCready D.R.; Seth A.; Marks A.; Marks A.

-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells
pp. 153-166(14)
Authors: Slotkin T.A.; Zhang J.; Dancel R.; Garcia S.J.; Willis C.; Seidler F.J.

Eye problems in breast cancer patients treated with tamoxifen
pp. 167-172(6)
Authors: Paganini-Hill A.; Clark L.J.

Analysis of cathepsin D in human breast cancer: Usefulness of the processsed 31 kDa active form of the enzyme as a prognostic indicator in node-negative and node-positive patients
pp. 173-179(7)
Authors: Riley L.B.; Lange M.K.; Browne R.J.; Cochrane P.J.; Choi I-J.; Davis B.; Arcona S.; Alhadeff J.A.

EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer
pp. 181-188(8)
Authors: Hamilton A.; Roy J.-A.; Beex L.; Piccart M.; Mauriac L.; Coleman R.; Paridaens R.; Boes G.H.; Vreckem A.v.; Palmer P.; Klijn J.